Bodal Chemicals Limited has informed the Exchange about Transcript
BODALCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bodal Chemicals reported Q1 FY26 consolidated revenue of INR458 crores, up 8% year-on-year, with EBITDA at INR52 crores (up 40% YoY) at a margin of 11.3%. Standalone PAT was INR10.34 crores while consolidated PAT stood at INR9.53 crores. Dye Intermediates revenue dipped 4% YoY to INR150 crores and Dyestuff fell 10% to INR122 crores due to lower raw material and finished product prices, while Basic Chemicals grew 15% to INR45 crores and Chlor-alkali grew 8% to INR84 crores. The new benzene derivatives unit at Saykha contributed INR13 crores at just 20% capacity utilization, with management guiding to 70-80% utilization by Q3-Q4 FY26. TCCA contributed only INR3.2 crores as pre-duty import inventory cleared, but management expects meaningful pickup in Q3-Q4 FY26 after the anti-dumping duty takes effect.
Management reiterated FY26 revenue guidance of around INR1,900-1,950 crores and signaled margin improvement to 12-13% in the next year as benzene and TCCA businesses ramp up, which should support earnings. A clear debt reduction plan of INR150-175 crores in FY26, targeting debt-to-EBITDA of 2.5x, signals focus on balance sheet strengthening, which is positive for shareholders but near-term profitability remains pressured by under-utilized new units.